Kingsview Wealth Management, LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1791965 GRANTS PASS, OR

Position in VRTX

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$243,364

-$16,864 QoQ

Shares Held

545

-5.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

Kingsview Wealth Management, LLC holds $3,730,947 across 13 Biotechnology names. VRTX ranks #7 (6.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VKTX	Viking Therapeutics, Inc.	21,975	$715,066
2	IMRX	Immuneering Corp	122,200	$643,994
3	REGN	Regeneron Pharmaceuticals, Inc.	739	$570,980
4	INSM	INSMED Inc	2,089	$341,593
5	AXSM	Axsome Therapeutics, Inc.	1,806	$305,250
6	INCY	Incyte Corp	3,134	$294,972
7	VRTX	Vertex Pharmaceuticals Inc / Ma This page	545	$243,364
8	TRVI	Trevi Therapeutics, Inc.	15,770	$188,136

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$243,364	545	-5.1%	Shares	Sole	2026-05-12
2025-12-31	$260,228	574	+2.3%	Shares	Sole	2026-02-09
2025-09-30	$219,710	561	+12.4%	Shares	Sole	2025-11-12
2025-06-30	$222,154	499	-8.4%	Shares	Sole	2025-08-08
2025-03-31	$264,226	545	+21.9%	Shares	Sole	2025-05-02
2024-09-30	$207,890	447	-67.5%	Shares	Sole	2024-11-12
2022-12-31	$397,361	1,376	-44.9%	Shares	Sole	2023-02-13
2022-06-30	$704,193	2,499	-5.3%	Shares	Sole	2022-08-16
2022-03-31	$688,438	2,638	-3.6%	Shares	Sole	2024-02-08
2021-12-31	$601,045	2,737	-4.9%	Shares	Sole	2022-02-17
2021-09-30	$521,859	2,877	-1.2%	Shares	Sole	2021-12-03
2021-06-30	$587,146	2,912	+2.8%	Shares	Sole	2021-08-17
2021-03-31	$608,998	2,834	-23.7%	Shares	Sole	2021-05-24
2020-12-31	$878,003	3,715	+52.6%	Shares	Sole	2021-02-16
2020-09-30	$662,340	2,434	—	Shares	Sole	2020-11-19
No filing history on record for this holder in this stock.